GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·DELAWARE·Filed: Sep 29, 2026
Total Offering

$38,958,054

Amount Sold

$7,750,000

Investors

9

First Sale

Sep 14, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Michael Breen
Related Person
Alan Urban
Related Person
Charles J. Casamento
Related Person
Hilary Kramer
Related Person
David C. Mun-Gavin
Related Person

Company

GT Biopharma, Inc.

505 MONTGOMERY STREET

SAN FRANCISCO, CA, 94111

(415) 919-4040

SEC Filing

0000109657-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free